Cargando…

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia

Detalles Bibliográficos
Autores principales:	Bourinbaiar, Aldar, Orlovsky, Vladimir, Jirathitikal, Vichai, Metadilogkul, Orapun, Dmitry, Popov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316013/ http://dx.doi.org/10.1186/1742-4690-7-S1-P30

Ejemplares similares

Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor
por: Metadilogkul, Orapun, et al.
Publicado: (2009)

Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study
por: Bourinbaiar, Aldar S, et al.
Publicado: (2010)

Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC
por: Tarakanovskaya, Marina G, et al.
Publicado: (2015)

Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB
por: Butov, Dmitry A, et al.
Publicado: (2011)

Hepatitis E virus seroprevalence in patients with HIV in Nizhny Novgorod, Russia
por: Sharipova, IN, et al.
Publicado: (2014)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit
por: Palanisamy, Saraswathy, et al.
Publicado: (2012)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
por: Deloof, ACA, et al.
Publicado: (2010)

The study of hepatitis B surface antigen and anti-HCV in HIV infected patients
por: Girish, N, et al.
Publicado: (2012)

Transmission of HIV, HBV, HCV in health settings: an anthropological approach on hygiene in Cambodia
por: Hancart-Petitet, Pascale, et al.
Publicado: (2011)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
por: Meijide, Héctor, et al.
Publicado: (2010)

Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients
por: Ferrara, S, et al.
Publicado: (2010)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Immune response characterization in HIV/HCV co-infected patients of medicine tropical foundation
por: Malheiro, Adriana, et al.
Publicado: (2010)

The results of a study on the prevalence of HIV, HCV and HBV genotypes in some regions of Ukraine
por: Yurchenko, et al.
Publicado: (2012)

Behavioral factors associated with HCV and HIV co-infection in residents of São Paulo, Brazil
por: Farias, Norma, et al.
Publicado: (2012)

Viral variability study in follow-up sera from HIV-HBV-HCV coninfected patients
por: Taffon, Stefania, et al.
Publicado: (2010)

Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
por: Sasongko, Priyo
Publicado: (2006)

Factors associated with HIV and HCV infection among individuals with a history of injection drug use in Baltimore
por: Severtson, SG, et al.
Publicado: (2006)

HIV/AIDS epidemic in Belarus
por: Eremin, Vladimir, et al.
Publicado: (2010)

Correlation of regional surveillance system with changes in epidemiology of HIV infection in Nizhny Novgorod Region, Russia from 2006-2010
por: Govinden, Kughan, et al.
Publicado: (2013)

HIV epidemic in Russia and neighbouring countries
por: Pokrovskiy, Vadim
Publicado: (2014)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
por: Chantry, AS, et al.
Publicado: (2014)

British HIV and ageing study. HIV and ageing: older people with HIV, who are they?
por: Allan, S, et al.
Publicado: (2010)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

2232. Zinc deficiency and advanced liver fibrosis among HIV/HCV co-infected persons in Russia
por: Barocas, Joshua, et al.
Publicado: (2018)

The cascade of HIV care in Russia, 2011–2013
por: Pokrovskaya, Anastasia, et al.
Publicado: (2014)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
por: Bhatti, L, et al.
Publicado: (2010)

P06-02. High prevalences of HIV, HCV, HBV and Treponema pallidum in male and trans sex workers from Argentina
por: Farías, M dos Ramos, et al.
Publicado: (2009)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant
por: Fernandez-Ortega, C, et al.
Publicado: (2010)

Effects of HIV related stigma on the lives of persons living with HIV
por: Parameswari, SJ, et al.
Publicado: (2012)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Access of high technology medicines in Russia
por: Bezmelnitsyna, Liudmila, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oi6oimp1kbli7a9pdrippo43e0